Prot #FF-10101-US101/201: A First-in-Human Phase 1/2a Study to Assess the Safety, Tolerability, Efficacy, and Pharmacokinetics of FF-10101-01 in Subjects with Relapsed or Refractory Acute Myeloid Leukemia

Project: Research project

Project Details

StatusActive
Effective start/end date8/2/17 → 8/2/23

Funding

  • Quintiles, Inc. (Prot #FF-10101-US101/201)
  • FUJIFILM Pharmaceuticals U.S.A., Inc. (Prot #FF-10101-US101/201)